OrthAlign raises $15M to market their OrthAlign Plus device

OrthAlign, Inc. Completes $15M Round of Financing to Fuel OrthAlign Plus® Launch, Sales and Marketing Expansion, and International Markets Growth (press release)
 
OrthAlign, Inc., a privately held U.S. based medical device and technology company, announced today the completion of a $15.0 million preferred series capital raise led by current OrthAlign investors, River Cities Capital Funds, a growth equity firm investing in healthcare and IT companies, and Mutual Capital Partners, a venture fund investing in rapidly growing, post-revenue technology businesses. The growth capital w...